http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002541815-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002541815-A |
| titleOfInvention | Recombinant and mutant adenoviruses derived from bovine adenovirus type 1 |
| abstract | (57) [Summary]nThe present invention provides a viral vector. In one embodiment, the invention provides a mutant bovine adenovirus and a recombinant bovine adenovirus having a deletion and / or insertion of DNA in the early gene region 4 (E4). In another embodiment, the invention provides a mutant bovine adenovirus 1 virus and a recombinant bovine adenovirus 1 virus having a deletion and / or insertion of a DNA in the early gene region 3 (E3). The invention also contemplates the use of viral vectors for vaccination, gene therapy or other applications where appropriate. |
| priorityDate | 1999-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.